Fortitude Advisory Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-40
Closed -$20K 513
2022
Q1
$20K Buy
+40
New +$18.3K 0.01% 828

Other funds holding ELV

Fortitude Advisory Group's ELV Position: Q2 2022 in Review

Fortitude Advisory Group sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 40 shares — an estimated $20K sold.

Fortitude Advisory Group first reported a position in ELV in Q1 2022 and held it in 1 quarter. The position peaked at $20K in Q1 2022. 1,440 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

  • Fortitude Advisory Group reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
  • Fortitude Advisory Group sold 40 Elevance Health shares in Q2 2022, an estimated $20K.
  • Fortitude Advisory Group first reported a position in Elevance Health in Q1 2022 and held it in 1 quarter.
  • Fortitude Advisory Group's Elevance Health position peaked at $20K in Q1 2022.
  • 1,440 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Fortitude Advisory Group's 13F filing for Q2 2022, filed 16 Aug 2022.